Compare Live Nation Entertainment, Inc. (LYV) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Medpace Holdings Inc — how do they compare? Live Nation Entertainment, Inc. trades at $178 (market cap $42.09B), while Medpace Holdings Inc trades at $519.93 (market cap $15.08B). The key difference: Live Nation Entertainment, Inc. is far larger — about 2.8× Medpace Holdings Inc's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| LYV | MEDP | |
|---|---|---|
Market Cap | $42.09B | $15.08B |
Sector | Industrials | Technology |
52-Week High | $186.59 | $620.59 |
52-Week Low | $125.61 | $308.88 |
Enterprise Value | $43.59B | $14.55B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Live Nation (LYV) trades at $180.84, up 0.34% today, with bullish technical signals from moving averages despite recent earnings misses. The company reported $25.2B revenue for 2025 with a slim 0.33% net margin, while valuation metrics show elevated P/E (117.49) and P/B (136.72) ratios. Recent news highlights executive share sales and ongoing legal scrutiny, though analyst consensus remains strongly bullish with an $200.20 price target.
Outlook remains mixed with strong revenue growth potential from concert demand and ticketing margins offset by profitability challenges and legal overhangs. The stock offers upside to analyst targets but faces execution risks amid high valuations and recent earnings volatility.
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
